EUVIMEDEUVIMED entdecken
Crossref

Cannabinoid Hyperemesis Syndrome

Thangam Venkatesan, William L Hasler, Michael Camilleri

JAMA · 10.11.2026 · 336 (18) · 1642

DOI: 10.1001/jama.2026.7873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 10.11.2026. Verfasst von Thangam Venkatesan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University, Columbus. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This JAMA Insights discusses cannabinoid hyperemesis syndrome, including pathophysiology, clinical presentation, and the epidemiology and risk factors.

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University, Columbus.
  • Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Scottsdale.
  • Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic Minnesota, Rochester.

Zitieren

APA

Venkatesan, T., Hasler, W. L., & Camilleri, M. (2026). Cannabinoid Hyperemesis Syndrome. JAMA, 336(18), 1642. https://doi.org/10.1001/jama.2026.7873

Vancouver

Venkatesan T, Hasler WL, Camilleri M. Cannabinoid Hyperemesis Syndrome. JAMA. 2026;336(18):1642. doi:10.1001/jama.2026.7873

BibTeX
@article{Venkatesan2026,
  author = {Venkatesan, Thangam and Hasler, William L and Camilleri, Michael},
  title = {Cannabinoid Hyperemesis Syndrome},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {18},
  pages = {1642},
  doi = {10.1001/jama.2026.7873}
}
Kostenlos starten →